Company news
Biofrontera Inc. news in 2021
Biofrontera Inc.'s news releases, calls and decks from 2021, newest first.
Biofrontera Inc. announces reduction of Biofrontera AG shareholding to less than 50% through warrant exercises
December 29, 2021
Biofrontera Inc. Announces Enrollment of First Subject in Phase 2b Clinical Trial Evaluating Ameluz® + BF-RhodoLED® in Moderate-to-Severe Acne
December 12, 2021
Biofrontera Inc. Announces Notice of Allowance for U.S. Method-of-Use Patent on PDT-lamp
December 7, 2021
Biofrontera Inc. Enrolls First Subject in Phase 1 Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz®
December 5, 2021
Biofrontera Inc. Announces Notice of Allowance for U.S. Patent on Innovative Illumination Protocol
December 1, 2021
Biofrontera Inc. Announces Closing of $15 Million Private Placement
November 30, 2021
Biofrontera Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update
November 29, 2021
Biofrontera Inc. Pricing of $15 Million Private Placement Priced At-the-Market Under Nasdaq Rules
November 28, 2021
Biofrontera Inc. to Report Third Quarter Financial Results on November 30, 2021
November 22, 2021
Biofrontera Kicks Off US Clinical Study Program for Ameluz®
November 15, 2021
Biofrontera Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Warrants
November 1, 2021
Biofrontera Inc. Announces Pricing of $18.0 Million Initial Public Offering
October 27, 2021